Then, in 2025, Ozempic was approved to help reduce the risk of kidney disease progression, kidney failure, and cardiovascular-related death in people with type 2 diabetes and chronic kidney disease, broadening its role in long-term diabetes care
It sounds a cautionary note for short-term use without a more comprehensive approach to weight management. Overeating far more likely Adam Collins, associate professor of nutrition at the University of Surrey in England, who was not involved in the study, called the paper timely and important. Collins underlined that weight regain is a common issue in all weight loss interventions, but the paper shows that this problem is amplified with GLP-1 medications
Is depression more frequent in late-life - an honest look at the evidence
Hair loss typically appears 2 to 3 months after starting GLP-1 injections or after a dose increase
Wegovy is approved for adults and pediatric patients aged 12 years and older with obesity
They did not study the effects on skin pigmentation, but this study did reaffirm the rapid absorption of reduced glutathione from oral mucosa to reach high serum concentrations which can have therapeutic value in many areas
